| 000 | 01877 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250518052919.0 | ||
| 264 | 0 | _c20200625 | |
| 008 | 202006s 0 0 eng d | ||
| 022 | _a1935-5548 | ||
| 024 | 7 |
_a10.2337/dc19-0937 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _avan Raalte, Daniël H | |
| 245 | 0 | 0 |
_aThe Impact of Sotagliflozin on Renal Function, Albuminuria, Blood Pressure, and Hematocrit in Adults With Type 1 Diabetes. _h[electronic resource] |
| 260 |
_bDiabetes care _c10 2019 |
||
| 300 |
_a1921-1929 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAlbuminuria _xdrug therapy |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 1 _xblood |
| 650 | 0 | 4 |
_aDiabetic Nephropathies _xdrug therapy |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlomerular Filtration Rate _xdrug effects |
| 650 | 0 | 4 |
_aGlycosides _xadministration & dosage |
| 650 | 0 | 4 | _aHematocrit |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aInsulin _xadministration & dosage |
| 650 | 0 | 4 |
_aKidney _xphysiopathology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aSodium-Glucose Transporter 2 Inhibitors _xadministration & dosage |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aBjornstad, Petter | |
| 700 | 1 | _aPersson, Frederik | |
| 700 | 1 | _aPowell, David R | |
| 700 | 1 | _ade Cassia Castro, Rita | |
| 700 | 1 | _aWang, Ping Stella | |
| 700 | 1 | _aLiu, Minzhi | |
| 700 | 1 | _aHeerspink, Hiddo J L | |
| 700 | 1 | _aCherney, David | |
| 773 | 0 |
_tDiabetes care _gvol. 42 _gno. 10 _gp. 1921-1929 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2337/dc19-0937 _zAvailable from publisher's website |
| 999 |
_c29965385 _d29965385 |
||